Loar Group

Loar Group

Robert Loar founded the Loar Group in 1996 as a single-family office to manage the wealth generated by Cima Labs, a drug-delivery technology company he co-founded. Cima Labs was acquired by Cephalon in 2004 for $512 million (per SEC filings, 2004). The firm operates from New York City and focuses on preserving and growing the family's capital through direct investments. The family office allocates across three core asset classes: real estate, private credit, and healthcare services. In real estate, Loar Group owns and manages commercial properties, including office and retail assets in the Northeastern US. Its private credit activities involve direct lending and structured finance transactions. Healthcare investments span specialty pharmaceutical and medical services companies, leveraging the family's industry expertise. The firm structures most deals as direct holdings or through wholly owned operating entities, avoiding third-party fund-of-funds structures. Loar Group maintains a lean team, with a small number of investment professionals and advisors. The firm does not disclose total AUM or deployment numbers. Philanthropic activity includes the Loar Family Foundation, which supports medical research and education. The office rarely engages with external GPs, preferring proprietary deal sourcing through its network of industry contacts. A structural differentiator is Loar Group's operating-company model: rather than acting solely as a passive investment vehicle, the firm acquires and operates businesses outright, particularly in healthcare and real estate. This approach integrates operational control with capital deployment, creating a hybrid between a traditional family office and a holding company.